Induction of beta-lactamase by various beta-lactam antibiotics in Enterobacter cloacae.

Antimicrobial Agents and Chemotherapy
S MinamiS Mitsuhashi

Abstract

The induction of beta-lactamase in Enterobacter cloacae GN5797 was studied by using 23 beta-lactam antiobiotics, including newly introduced drugs, as inducers. the beta-lactam antibiotics can be classified into three groups on the basis of their inducer activity. Among the tested cephalosporins, cephamycin derivatives such as cefoxitin, cefmetazole, and YM09330 had high inducer activity even at low drug concentrations. On the other hand, cefoperazone, cefsulodin, piperacillin, and apalcillin showed low inducer activity when compared with the other cephalosporins.

References

Jul 1, 1979·The Journal of Antimicrobial Chemotherapy·M Matthew
Jun 1, 1976·The Journal of Antimicrobial Chemotherapy·R B Sykes, M Matthew
Dec 1, 1974·Antimicrobial Agents and Chemotherapy·K Nordström, R B Sykes
Dec 1, 1974·Antimicrobial Agents and Chemotherapy·K Nordström, R B Sykes
Jun 1, 1974·The Biochemical Journal·S G Waley
Jan 1, 1973·Advances in Microbial Physiology·M H Richmond, R B Sykes
Nov 1, 1967·Journal of General Microbiology·T D Hennessey
May 1, 1962·The Biochemical Journal·R P NOVICK
May 1, 1962·The Biochemical Journal·R P NOVICK

❮ Previous
Next ❯

Citations

Aug 1, 1987·European Journal of Clinical Microbiology·D M Livermore
Aug 1, 1987·European Journal of Clinical Microbiology·F Tausk, C W Stratton
Oct 1, 1987·European Journal of Clinical Microbiology·M HiraokaS Mitsuhashi
Sep 1, 1989·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M D KitzisL Gutmann
Jan 1, 1993·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·I Phillips, K Shannon
May 1, 1994·The Journal of Hospital Infection·N al AnsariE G Smyth
Jun 23, 1998·Diagnostic Microbiology and Infectious Disease·R N Jones
Mar 27, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·K Bush
Jan 7, 1999·The Pediatric Infectious Disease Journal·S M Abdel-Rahman, G L Kearns
Apr 1, 1982·Antimicrobial Agents and Chemotherapy·M F LampeJ C Sherris
Oct 1, 1982·Antimicrobial Agents and Chemotherapy·A Iravani, G A Richard
Jan 1, 1983·Antimicrobial Agents and Chemotherapy·T D Gootz, C C Sanders
Dec 1, 1983·Antimicrobial Agents and Chemotherapy·A YotsujiS Mitsuhashi
May 1, 1984·Antimicrobial Agents and Chemotherapy·T D GootzJ C Sherris
Oct 1, 1984·Antimicrobial Agents and Chemotherapy·D H WuP E Conley
Nov 1, 1984·Antimicrobial Agents and Chemotherapy·J M LacroixF Malouin
Apr 1, 1985·Antimicrobial Agents and Chemotherapy·T FujiiS Mitsuhashi
Jul 1, 1985·Antimicrobial Agents and Chemotherapy·F TauskC W Stratton
Dec 1, 1985·Antimicrobial Agents and Chemotherapy·A YotsujiS Mitsuhashi
Apr 1, 1986·Antimicrobial Agents and Chemotherapy·E YokotaS Mitsuhashi
May 1, 1986·Antimicrobial Agents and Chemotherapy·T FujiiS Mitsuhashi
Oct 1, 1986·Antimicrobial Agents and Chemotherapy·F Tausk, C W Stratton
Nov 1, 1986·Antimicrobial Agents and Chemotherapy·R L Then, P Angehrn
Nov 1, 1986·Antimicrobial Agents and Chemotherapy·S KobayashiK Fujimoto
Nov 1, 1986·Antimicrobial Agents and Chemotherapy·F MalouinJ M Lacroix
Jun 1, 1987·Antimicrobial Agents and Chemotherapy·Y IkedaT Tanino
Nov 1, 1988·Antimicrobial Agents and Chemotherapy·E YourassowskyY Glupczynski
Dec 1, 1989·Antimicrobial Agents and Chemotherapy·E Inoue, S Mitsuhashi
Mar 1, 1989·Antimicrobial Agents and Chemotherapy·M HiraokaS Mitsuhashi
Mar 1, 1989·Antimicrobial Agents and Chemotherapy·S SatakeS Mitsuhashi
Aug 1, 1989·Antimicrobial Agents and Chemotherapy·T KesadoC E Nord
Jan 1, 1990·Antimicrobial Agents and Chemotherapy·D A Weber, C C Sanders
Jan 1, 1991·Antimicrobial Agents and Chemotherapy·F BellidoR E Hancock

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.